209 related articles for article (PubMed ID: 35927740)
1. A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.
Levin JB; Briggs F; Blixen C; Bauer M; Einstadter D; Albert JM; Weise C; Woods N; Fuentes-Casiano E; Cassidy KA; Rentsch J; Sarna K; Sajatovic M
Trials; 2022 Aug; 23(1):634. PubMed ID: 35927740
[TBL] [Abstract][Full Text] [Related]
2. Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial.
Levin JB; Moore DJ; Depp C; Montoya JL; Briggs F; Rahman M; Stange KC; Einstadter D; Weise C; Conroy C; Yala J; Radatz E; Sajatovic M
Trials; 2022 Jun; 23(1):539. PubMed ID: 35768875
[TBL] [Abstract][Full Text] [Related]
3. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
[TBL] [Abstract][Full Text] [Related]
4. Promoting medication adherence among patients with bipolar disorder: a multicenter randomized controlled trial of a multifaceted intervention.
Pakpour AH; Modabbernia A; Lin CY; Saffari M; Ahmadzad Asl M; Webb TL
Psychol Med; 2017 Oct; 47(14):2528-2539. PubMed ID: 28446253
[TBL] [Abstract][Full Text] [Related]
5. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.
Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Fuentes-Casiano E; Bialko CS; Cassidy KA
Bipolar Disord; 2012 May; 14(3):291-300. PubMed ID: 22548902
[TBL] [Abstract][Full Text] [Related]
6. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.
Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Williams TD; Bialko CS; Cassidy KA
Psychiatr Serv; 2012 Feb; 63(2):176-8. PubMed ID: 22302337
[TBL] [Abstract][Full Text] [Related]
7. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report.
McVoy M; Delbello M; Levin J; Modi AC; Forthun LF; Briggs F; Appling D; Broadnax M; Conroy C; Cooley R; Eapen G; Sajatovic M
Contemp Clin Trials; 2022 Apr; 115():106729. PubMed ID: 35278693
[TBL] [Abstract][Full Text] [Related]
8. Enhancing medication adherence in patients with bipolar disorder.
Berk L; Hallam KT; Colom F; Vieta E; Hasty M; Macneil C; Berk M
Hum Psychopharmacol; 2010 Jan; 25(1):1-16. PubMed ID: 20041478
[TBL] [Abstract][Full Text] [Related]
9. Age-Related Differences in Medication Adherence, Symptoms, and Stigma in Poorly Adherent Adults With Bipolar Disorder.
Smilowitz S; Aftab A; Aebi M; Levin J; Tatsuoka C; Sajatovic M
J Geriatr Psychiatry Neurol; 2020 Sep; 33(5):250-255. PubMed ID: 31542988
[TBL] [Abstract][Full Text] [Related]
10. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder.
Sajatovic M; Levin JB; Ramirez LF; Cassidy KA; McNamara N; Fuentes-Casiano E; Wilson B; Appling D; S FB
Prim Care Companion CNS Disord; 2021 Sep; 23(5):. PubMed ID: 34534421
[No Abstract] [Full Text] [Related]
11. Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial.
Faurholt-Jepsen M; Vinberg M; Frost M; Christensen EM; Bardram J; Kessing LV
BMC Psychiatry; 2014 Nov; 14():309. PubMed ID: 25420431
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
14. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.
Sajatovic M; Levin J; Fuentes-Casiano E; Cassidy KA; Tatsuoka C; Jenkins JH
Compr Psychiatry; 2011; 52(3):280-7. PubMed ID: 21497222
[TBL] [Abstract][Full Text] [Related]
15. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
[TBL] [Abstract][Full Text] [Related]
16. An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
Mbwambo J; Kaaya S; Lema I; Burant CJ; Magwiza C; Madundo K; Njiro G; Blixen CE; Cassidy KA; Levin JB; Sajatovic M
BMC Psychiatry; 2022 Jan; 22(1):62. PubMed ID: 35086504
[TBL] [Abstract][Full Text] [Related]
17. Reducing the rate and duration of Re-ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment - the RADMIS trials: study protocol for two randomized controlled trials.
Faurholt-Jepsen M; Frost M; Martiny K; Tuxen N; Rosenberg N; Busk J; Winther O; Bardram JE; Kessing LV
Trials; 2017 Jun; 18(1):277. PubMed ID: 28619114
[TBL] [Abstract][Full Text] [Related]
18. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.
Sajatovic M; Levin J; Ramirez LF; Hahn DY; Tatsuoka C; Bialko CS; Cassidy KA; Fuentes-Casiano E; Williams TD
J Clin Psychiatry; 2013 Dec; 74(12):1249-55. PubMed ID: 24434094
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. The effect of smartphone-based monitoring and treatment including clinical feedback versus smartphone-based monitoring without clinical feedback in bipolar disorder: the SmartBipolar trial-a study protocol for a randomized controlled parallel-group trial.
Faurholt-Jepsen M; Kyster NB; Dyreholt MS; Christensen EM; Bondo-Kozuch P; Lerche AS; Smidt B; Knorr U; Brøndmark K; Cardoso AB; Mathiesen A; Sjælland R; Nørbak-Emig H; Sponsor LL; Mardosas D; Sarauw-Nielsen IP; Bukh JD; Heller TV; Frost M; Iversen N; Bardram JE; Busk J; Vinberg M; Kessing LV
Trials; 2023 Sep; 24(1):583. PubMed ID: 37700334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
